Platelet to Lymphocyte Ratio as a Predictive Tool for the Perioperative and Postoperative Outcomes in Advanced Stage Ovarian Cancer

被引:0
|
作者
Balescu, Irina [1 ]
Brezean, Iulian [2 ,3 ]
Cauni, Victor [4 ]
Petrea, Sorin [2 ,3 ]
Diaconu, Camelia [5 ,6 ]
Gaspar, Bogdan [2 ,7 ]
Ciuvica, Adriana [8 ,9 ]
Nistor, Claudiu Eduard [10 ,11 ]
Ciuche, Adrian [10 ,11 ]
Varlas, Valentin [8 ,12 ]
Bacalbasa, Nicolae [2 ,13 ]
机构
[1] Carol Davila Univ Med & Pharm, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Dept Surg, Bucharest, Romania
[3] Ion Cantacuzino Clin Hosp, Dept Surg, Bucharest, Romania
[4] Colentina Clin Hosp, Dept Urol, Bucharest, Romania
[5] Floreasca Clin Emergency Hosp, Dept Internal Med, Bucharest, Romania
[6] Carol Davila Univ Med & Pharm, Dept Internal Med, Bucharest, Romania
[7] Floreasca Clin Emergency Hosp, Dept Visceral Surg, Bucharest, Romania
[8] Carol Davila Univ Med & Pharm, Dept Obstet & Gynecol, Bucharest, Romania
[9] Natl Inst Mother & Child Care Alessandrescu Ruses, Dept Obstet & Gynecol, Bucharest, Romania
[10] Carol Davila Univ Med & Pharm, Cardiothorac Pathol, Thorac Surg Discipline, Bucharest, Romania
[11] Carol Davila Cent Emergency Univ Mil Hosp, Thorac Surg Dept, Bucharest, Romania
[12] Filantropia Clin Hosp, Dept Obstet & Gynecol, Bucharest, Romania
[13] Fundeni Clin Inst, Dept Visceral Surg, Ctr Excellence Translat Med, Bucharest 022328, Romania
关键词
advanced stage ovarian cancer; platelet to lymphocyte ratio; mean overall survival rate; postoperative complications; INFLAMMATION; METASTASIS; NEUTROPHIL; CA125;
D O I
10.21614/chirurgia.2023.v.118.i.4.p.417
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: platelet to lymphocyte ratio remains a significant prognostic factor in different malignancies. The aim of the current paper is to study the correlation between the preoperative values of platelet to lymphocyte ratio (PLR) and the postoperative outcomes in ovarian cancer patients. Method: we conducted a retrospective study on 57 patients submitted to cytoreductive surgery between 2014-2020. We determined the optimal cut off value of PLR for predicting survival outcomes by using the Receiver Operating Characteristic curve a value of 350 being obtained. The patients were further classified in two groups according to the PLR value. Results: there were 37 patients with PLR<350 and respectively 20 patients with PLR>350. Patients in the second group were significantly older and presented significantly higher rates of perioperative complications, a significantly higher level of circulating platelets, of CA125 and respectively a significantly lower level of circulating lymphocytes and of preoperative hemoglobin level. Meanwhile, patients in the second group reported a significantly poorer disease free and overall survival. Conclusions: ovarian cancer patients with higher preoperative levels of PLR trend to have a poorer early and long-term postoperative outcome. Therefore, in such cases more aggressive systemic therapies might be needed.
引用
收藏
页码:417 / 425
页数:9
相关论文
共 50 条
  • [21] Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Predictive Markers for Pulmonary Embolism
    Singh, H.
    Cotarelo, A.
    Samarneh, M. M.
    Rampersaud, R.
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (04) : S111 - S112
  • [22] Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer
    Sanna, Elisabetta
    Tanca, Luciana
    Cherchi, Cristina
    Gramignano, Giulia
    Oppi, Sara
    Chiai, Maria Gloria
    Maccio, Antonio
    Madeddu, Clelia
    DIAGNOSTICS, 2021, 11 (07)
  • [23] Platelet count, platelet lymphocyte ratio, and Ki67 as a predictive factor of neoadjuvant chemotherapy response in locally advanced breast cancer
    Priyono, Sasongko Hadi
    Badriatunnor
    Noor, Meitria Syahadatina
    Wibowo, Agung Ary
    Sanyoto, Didik Dwi
    Ardansyah, Audi
    BALI MEDICAL JOURNAL, 2023, 12 (02) : 1703 - 1707
  • [24] Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and hemoglobin (Hb) predict immunotherapy outcomes in patients with advanced or metastatic gastric cancer.
    Gou, Miaomiao
    Zhang, Yong
    Yan, Huan
    Si, Haiyan
    Wang, Zhikuan
    Dai, Guanghai
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage Ⅲ and Ⅳ colorectal cancer
    Jae Hyun Kim
    Jun Yeop Lee
    Hae Koo Kim
    Jin Wook Lee
    Sung Gyu Jung
    Kyoungwon Jung
    Sung Eun Kim
    Won Moon
    Moo In Park
    Seun Ja Park
    World Journal of Gastroenterology, 2017, (03) : 505 - 515
  • [26] The analysis of the prognostic value of the neutrophil/lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients
    Muzykiewicz, Konrad Piotr
    Iwanska, Ewa
    Janeczek, Maja
    Glanowska, Izabela
    Karolewski, Kaziemierz
    Blecharz, Pawel
    GINEKOLOGIA POLSKA, 2021, 92 (01) : 16 - 23
  • [27] Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in locally advanced rectal cancer
    Duque-Santana, Victor
    Lopez-Campos, Fernando
    Martin-Martin, Margarita
    Valero, Mireia
    Zafra-Martin, Juan
    Counago, Felipe
    Sancho, Sonsoles
    ONCOLOGY, 2023, 101 (06) : 349 - 357
  • [28] Correlation between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and postoperative cognitive dysfunction in elderly patients with esophageal cancer
    Zhao, Jie
    Dai, Tingting
    Ding, Ling
    Liang, Yu
    Yuan, Wanshi
    Jiang, Yunqin
    Zheng, Yifeng
    MEDICINE, 2023, 102 (10)
  • [29] Predictive Value of Preoperative Neutrophil- Lymphocyte and Platelet-Lymphocyte Ratio in Determining the Stage of Colon Tumors
    Turhan, Veysel Baris
    Unsal, Abdulkadir
    Gok, Halil Fatih
    Ozturk, Bulent
    Ozturk, Dogan
    Simsek, Gulcin Guler
    Bulus, Hakan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [30] PLATELET-TO-LYMPHOCYTE RATIO AND CA 125 AS A PREDICTOR OF OUTCOME IN OVARIAN CANCER
    Iavazzo, C.
    Datta, M.
    McComiskey, M.
    Slade, R.
    Ryan, M.
    Winter-Roach, B.
    Smith, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1438 - 1438